Handelsbanken Fonder’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Buy
32,506
+4,000
+14% +$168K 0.01% 829
2026
Q1
$918K Hold
28,506
﹤0.01% 1081
2025
Q4
$1.2M Buy
28,506
+4,500
+19% +$181K ﹤0.01% 957
2025
Q3
$824K Hold
24,006
﹤0.01% 1083
2025
Q2
$649K Sell
24,006
-2,200
-8% -$63.7K ﹤0.01% 1140
2025
Q1
$777K Hold
26,206
﹤0.01% 1052
2024
Q4
$1.04M Sell
26,206
-1,200
-4% -$45.4K ﹤0.01% 954
2024
Q3
$933K Buy
27,406
+5,400
+25% +$152K ﹤0.01% 981
2024
Q2
$477K Buy
22,006
+2,100
+11% +$44.2K ﹤0.01% 1179
2024
Q1
$441K Hold
19,906
﹤0.01% 1222
2023
Q4
$548K Sell
19,906
-1,100
-5% -$26.6K ﹤0.01% 1107
2023
Q3
$469K Buy
21,006
+6,631
+46% +$171K ﹤0.01% 1077
2023
Q2
$366K Hold
14,375
﹤0.01% 1242
2023
Q1
$321K Hold
14,375
﹤0.01% 1259
2022
Q4
$341K Buy
+14,375
New +$334K ﹤0.01% 1180
2022
Q2
Sell
-8,675
Closed -$239K 1695
2022
Q1
$239K Sell
8,675
-4,900
-36% -$140K ﹤0.01% 1591
2021
Q4
$559K Sell
13,575
-1,000
-7% -$44.2K ﹤0.01% 1274
2021
Q3
$677K Hold
14,575
﹤0.01% 1139
2021
Q2
$583K Buy
14,575
+2,800
+24% +$120K ﹤0.01% 1266
2021
Q1
$633K Hold
11,775
﹤0.01% 1068
2020
Q4
$576K Buy
11,775
+4,200
+55% +$195K ﹤0.01% 1087
2020
Q3
$246K Buy
+7,575
New +$241K ﹤0.01% 1325

Other funds holding VCYT

Handelsbanken Fonder's VCYT Position: Q2 2026 in Review

Handelsbanken Fonder increased its Veracyte (VCYT) stake by 14% in Q2 2026, buying an estimated $168K and bringing the position to 32,506 shares worth $1.91M. The position accounts for 0.01% of the portfolio, ranked #829.

Handelsbanken Fonder first reported a position in VCYT in Q3 2020 and has held it in 22 quarters since. 232 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Handelsbanken Fonder held 32,506 shares of Veracyte worth $1.91M as of Q2 2026.
  • Handelsbanken Fonder bought 4,000 Veracyte shares in Q2 2026, an estimated $168K.
  • Veracyte made up 0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #829 holding.
  • Handelsbanken Fonder first reported a position in Veracyte in Q3 2020 and has held it in 22 quarters since.
  • 232 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.